International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDopps.

Abstract:

BACKGROUND AND OBJECTIVES:Chronic kidney disease (CKD) is commonly associated with mineral and bone metabolism disorders, but these are less frequently studied in non-dialysis CKD patients than in dialysis patients. We examined and described international variation in mineral and bone disease (MBD) markers and their treatment and target levels in Stage 3-5 CKD patients. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS:Prospective cohort study of 7658 adult patients with eGFR <60mL/min/1.73m2, excluding dialysis or transplant patients, participating in the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) in Brazil, France, Germany, and the US. CKD-MBD laboratory markers included serum levels of phosphorus (P), calcium (Ca), intact parathyroid hormone (iPTH), and 25-hydroxyvitamin D (25-D). MBD treatment data included phosphate binders and vitamin D (nutritional and active). Nephrologist survey data were collected on target MBD marker levels. RESULTS:Over two-thirds of the patients had MBD markers measured at time intervals in line with practice guidelines. P and iPTH increased and Ca decreased gradually from eGFR 60-20mL/min/1.73m2 and more sharply for eGFR<20. 25-D showed no relation to eGFR. Nephrologist survey data indicated marked variation in upper target P and iPTH levels. Among patients with P>5.5mg/dL, phosphate binder use was 14% to 43% across the four countries. Among patients with PTH >300pg/mL, use of active (calcitriol and related analogs) vitamin D was 12%-51%, and use of any (active or nutritional) vitamin D was 60%-87%. CONCLUSIONS:Although monitoring of CKD-MBD laboratory markers by nephrologists in CKDopps countries is consistent with guidelines, target levels vary notably and prescription of medications to treat abnormalities in these laboratory markers is generally low in these cross-sectional analyses. While there are opportunities to increase treatment of hyperphosphatemia, hyperparathyroidism, and vitamin D deficiency in advanced CKD, the effect on longer-term complications of these conditions requires study.

journal_name

Bone

journal_title

Bone

authors

Liabeuf S,McCullough K,Young EW,Pisoni R,Zee J,Reichel H,Pecoits-Filho R,Port FK,Stengel B,Csomor PA,Metzger M,Robinson B,Massy ZA

doi

10.1016/j.bone.2019.115058

subject

Has Abstract

pub_date

2019-12-01 00:00:00

pages

115058

eissn

8756-3282

issn

1873-2763

pii

S8756-3282(19)30348-5

journal_volume

129

pub_type

杂志文章

相关文献

BONE文献大全
  • Skeletal phenotype of mandibuloacral dysplasia associated with mutations in ZMPSTE24.

    abstract::Mandibuloacral dysplasia (MAD) is a rare recessively inherited premature aging disease characterized by skeletal and metabolic anomalies. It is part of the spectrum of diseases called laminopathies and results from mutations in genes regulating the synthesis of the nuclear laminar protein, lamin A. Homozygous or compo...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.06.004

    authors: Cunningham VJ,D'Apice MR,Licata N,Novelli G,Cundy T

    更新日期:2010-09-01 00:00:00

  • The influence of clodronate on the torsional strength of the growing rat tibia in immobilization osteoporosis.

    abstract::The purpose was to investigate whether the reduction in bone mechanical strength induced by immobilization could be prevented by a bisphosphonate compound, clodronate. The torsional breaking strength of the tibia was measured using a specially constructed torsion machine. Maximum torque capacity, maximum angle of defo...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(94)90302-6

    authors: Lepola V,Jalovaara P,Väänänen K

    更新日期:1994-05-01 00:00:00

  • Function of Ca2+ in phosphatidylcholine-hydrolyzing phospholipase D activation in osteoblast-like cells.

    abstract::We investigated the function of Ca2+ in the activation of phosphatidylcholine (PC)-hydrolyzing phospholipase D (PLD) in osteoblast-like MC3T3-E1 cells. Fetal calf serum (FCS) stimulated the formation of choline in a dose-dependent manner in the range between 0.6% and 10%. The effect of a combination of FCS and 12-O-te...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(96)00185-8

    authors: Tokuda H,Suzuki A,Watanabe-Tomita Y,Shinoda J,Imamura Y,Oiso Y,Igata A,Kozawa O

    更新日期:1996-10-01 00:00:00

  • Plasminogen activators are involved in the degradation of bone by osteoclasts.

    abstract::Osteoclastic bone degradation depends on the activity of several proteolytic enzymes, in particular to those belonging to the classes of cysteine proteinases and matrix metalloproteinases (MMPs). Yet, several findings suggest that the two types of plasminogen activators (PA), the tissue- and urokinase-type PA (tPA and...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.07.004

    authors: Everts V,Daci E,Tigchelaar-Gutter W,Hoeben KA,Torrekens S,Carmeliet G,Beertsen W

    更新日期:2008-11-01 00:00:00

  • Globular adiponectin reverses osteo-sarcopenia and altered body composition in ovariectomized rats.

    abstract::Adiponectin regulates various metabolic processes including glucose flux, lipid breakdown and insulin response. We recently reported that adiponectin receptor1 (adipoR1) activation by a small molecule reverses osteopenia in leptin receptor deficient db/db (diabetic) mice. However, the role of adiponectin in bone metab...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.08.005

    authors: China SP,Pal S,Chattopadhyay S,Porwal K,Kushwaha S,Bhattacharyya S,Mittal M,Gurjar AA,Barbhuyan T,Singh AK,Trivedi AK,Gayen JR,Sanyal S,Chattopadhyay N

    更新日期:2017-12-01 00:00:00

  • Angiotensin II triggers knee joint lesions in experimental osteoarthritis.

    abstract:OBJECTIVES:This study aimed to evaluate the involvement of Angiotensin II (Ang II) in joint lesions associated with osteoarthritis (OA) in vitro and in vivo. METHODS:Chondrocyte cultures were obtained from knee joints of neonatal rats and stimulated with Ang II/MIA/ACE inhibitors. In vivo, rats treated or not with the...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2021.115842

    authors: de Sá GA,Dos Santos ACPM,Nogueira JM,Dos Santos DM,Amaral FA,Jorge EC,Caliari MV,Queiroz-Junior CM,Ferreira AJ

    更新日期:2021-01-07 00:00:00

  • LMP1 regulates periodontal ligament progenitor cell proliferation and differentiation.

    abstract::LMP1 is an intracellular scaffold protein that contains a PDZ domain and three LIM domains. LMP1 has multiple functions including regulating mesenchymal stem cell (MSC) osteogenesis. Gene delivery of LMP1 induces bone formation in vivo in heterotopic and orthotopic sites. However, little is known about the physiologic...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.03.013

    authors: Lin Z,Navarro VP,Kempeinen KM,Franco LM,Jin Q,Sugai JV,Giannobile WV

    更新日期:2010-07-01 00:00:00

  • Relationships between marrow fat and bone turnover in ovariectomized and intact rats.

    abstract::It is known that marrow fat content increases in a variety of osteoporoses. This study sought to clarify this phenomenon by combining bone and marrow histomorphometry, and to determine (1) whether the marrow fat increase follows or precedes diminishment of bone volume, and (2) whether the increase in fat volume is due...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(91)90011-7

    authors: Martin RB,Zissimos SL

    更新日期:1991-01-01 00:00:00

  • Bone adaptation: Safety factors and load predictability in shaping skeletal form.

    abstract::Much is known about skeletal adaptation in relation to the mechanical functions that bones serve. This includes how bone adapts to mechanical loading during an individual's lifetime as well as over evolutionary time. Although controlled loading in animal models allows us to observe short-term bone adaptation (epigenet...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2019.115114

    authors: Willie BM,Zimmermann EA,Vitienes I,Main RP,Komarova SV

    更新日期:2020-02-01 00:00:00

  • Low width of tubular bones is associated with increased risk of fragility fracture in elderly men--the MINOS study.

    abstract::The risk of fragility fractures in elderly men is only partly explained by areal bone mineral density (aBMD) measured by dual X-ray absorptiometry (DXA). Several studies suggest the importance of bone morphology for the risk of fracture. The aim of this study was to assess the value of bone size and estimated structur...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.09.004

    authors: Szulc P,Munoz F,Duboeuf F,Marchand F,Delmas PD

    更新日期:2006-04-01 00:00:00

  • Changes in vasoactive factors associated with altered vessel morphology in the tibial metaphysis during ovariectomy-induced bone loss in rats.

    abstract::We hypothesized that estrogen deficiency induces changes in bone vascularization which might be involved in bone loss mechanisms. First, we studied gene expression of angiogenic (vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2)) and vasodilator (endothelial nitric oxide synthase (ecNOS), n...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(03)00099-1

    authors: Mekraldi S,Lafage-Proust MH,Bloomfield S,Alexandre C,Vico L

    更新日期:2003-06-01 00:00:00

  • Comparison of peripheral bone and body axis skeleton in a rat model of mild-to-moderate renal failure in the presence of physiological serum levels of calcitropic hormones.

    abstract::The skeleton is characterized by anatomic heterogeneity of metabolic turnover. Site-dependent differences in hormonal effects seem likely. Hyporesponsiveness of osteoclasts to parathyroid hormone (PTH) and probably calcitriol was recently demonstrated in the fifth lumbar vertebra of a rat model with moderate renal fai...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(01)00502-6

    authors: Freesmeyer MG,Abendroth K,Faldum A,Krauss C,Stein G

    更新日期:2001-09-01 00:00:00

  • Contrast-enhanced micro-computed tomography of fatigue microdamage accumulation in human cortical bone.

    abstract::Conventional methods used to image and quantify microdamage accumulation in bone are limited to histological sections, which are inherently invasive, destructive, two-dimensional, and tedious. These limitations inhibit investigation of microdamage accumulation with respect to volumetric spatial variation in mechanical...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.10.160

    authors: Landrigan MD,Li J,Turnbull TL,Burr DB,Niebur GL,Roeder RK

    更新日期:2011-03-01 00:00:00

  • Very high bone mineral density in a monogenic form of obesity-associated insulin resistance.

    abstract:INTRODUCTION:Alström syndrome (ALMS) is an ultra-rare metabolic disorder caused by biallelic loss-of-function in the Alms1 gene which encodes a ubiquitously expressed centrosomal protein of the primary cilium. Although ALMS is characterised by several metabolic and hormonal dysfunctions that can lead to an increased ri...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115756

    authors: Tahani N,Choudhary S,Boivin C,Dawson C,Gittoes N,Geberhiwot T

    更新日期:2021-02-01 00:00:00

  • Long-term fatigue behavior of compact bone at low strain magnitude and rate.

    abstract::Fatigue behavior of compact bone at physiological strain ranges was examined in vitro. Standardized specimens of bovine compact bone were cyclically loaded in uniaxial tension of 0-1200 or 0-1500 microstrain for up to 13-37 million cycles to study the long-term fatigue properties. All specimens exhibited fatigue durin...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(90)90087-f

    authors: Schaffler MB,Radin EL,Burr DB

    更新日期:1990-01-01 00:00:00

  • Efficacy and safety of ibandronate given by intravenous injection once every 3 months.

    abstract::Oral bisphosphonates are established therapeutics for postmenopausal osteoporosis. Alternative, simplified dosing regimens that improve tolerability and promote convenience may be advantageous. Ibandronate is a highly potent, nitrogen-containing bisphosphonate that can be administered as a convenient intravenous (i.v....

    journal_title:Bone

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.bone.2004.01.007

    authors: Adami S,Felsenberg D,Christiansen C,Robinson J,Lorenc RS,Mahoney P,Coutant K,Schimmer RC,Delmas PD

    更新日期:2004-05-01 00:00:00

  • The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts.

    abstract::Bisphosphonates (BPs), bone targeted drugs that disrupt osteoclast function, are routinely used to treat complications of bone metastasis. Studies in preclinical models of cancer have shown that BPs reduce skeletal tumor burden and increase survival. Similarly, we observed in the present study that administration of t...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2009.01.010

    authors: Hirbe AC,Roelofs AJ,Floyd DH,Deng H,Becker SN,Lanigan LG,Apicelli AJ,Xu Z,Prior JL,Eagleton MC,Piwnica-Worms D,Rogers MJ,Weilbaecher K

    更新日期:2009-05-01 00:00:00

  • Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls.

    abstract::Sclerostin, product of the SOST gene, is an important determinant of bone formation and resorption. Adolescents with anorexia nervosa (AN) have low bone density and decreased levels of bone turnover markers. However, sclerostin has not been examined in AN as a potential mediator of impaired bone metabolism. Our study ...

    journal_title:Bone

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.bone.2012.06.006

    authors: Faje AT,Fazeli PK,Katzman DK,Miller KK,Breggia A,Rosen CJ,Mendes N,Klibanski A,Misra M

    更新日期:2012-09-01 00:00:00

  • Defining osteoblast and adipocyte lineages in the bone marrow.

    abstract::Bone is a complex endocrine organ that facilitates structural support, protection to vital organs, sites for hematopoiesis, and calcium homeostasis. The bone marrow microenvironment is a heterogeneous niche consisting of multipotent musculoskeletal and hematopoietic progenitors and their derivative terminal cell types...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2018.05.019

    authors: Pierce JL,Begun DL,Westendorf JJ,McGee-Lawrence ME

    更新日期:2019-01-01 00:00:00

  • Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone.

    abstract::Several Biophosphonates have been used as therapeutic agents for Paget's bone disease. (Chloro-4 phenyl)thiomethylene-bisphosphonate (CIPsMBP) has recently been shown to have significant antiosteoclastic activity while an affect of CIPsMBP on mineralization was only observed at high doses. We tested this drug for 6 mo...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/8756-3282(88)90115-9

    authors: Reginster JY,Jeugmans-Huynen AM,Albert A,Denis D,Deroisy R,Lecart MP,Fontaine MA,Collette J,Franchimont P

    更新日期:1988-01-01 00:00:00

  • Expression of amelogenin in odontoblasts.

    abstract::Amelogenin is the major enamel protein produced by ameloblasts. Its expression has been shown to be down-regulated in ameloblasts of vitamin-D-deficient (-D) rats. The potential expression and localization of amelogenin in odontoblasts and its regulation by vitamin D were investigated in this study. RT-PCR and semi-qu...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(02)00978-x

    authors: Papagerakis P,MacDougall M,Hotton D,Bailleul-Forestier I,Oboeuf M,Berdal A

    更新日期:2003-03-01 00:00:00

  • On the combined effects of normobaric hypoxia and bed rest upon bone and mineral metabolism: Results from the PlanHab study.

    abstract::Bone losses are common as a consequence of unloading and also in patients with chronic obstructive pulmonary disease (COPD). Although hypoxia has been implicated as an important factor to drive bone loss, its interaction with unloading remains unresolved. The objective therefore was to assess whether human bone loss c...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.bone.2016.07.013

    authors: Rittweger J,Debevec T,Frings-Meuthen P,Lau P,Mittag U,Ganse B,Ferstl PG,Simpson EJ,Macdonald IA,Eiken O,Mekjavic IB

    更新日期:2016-10-01 00:00:00

  • Bone structure in two adult subjects with impaired minor spliceosome function resulting from RNU4ATAC mutations causing microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1).

    abstract::Microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1), or Taybi-Linder syndrome is characterized by distinctive skeletal dysplasia, severe intrauterine and postnatal growth retardation, microcephaly, dysmorphic features, and neurological malformations. It is an autosomal recessive disorder caused by homozyg...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2016.08.023

    authors: Krøigård AB,Frost M,Larsen MJ,Ousager LB,Frederiksen AL

    更新日期:2016-11-01 00:00:00

  • Sclerostin deficiency in humans.

    abstract::Sclerosteosis and van Buchem disease are two rare bone sclerosing dysplasias caused by genetic defects in the synthesis of sclerostin. In this article we review the demographic, clinical, biochemical, radiological, and histological characteristics of patients with sclerosteosis and van Buchem disease that led to a bet...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2016.10.010

    authors: van Lierop AH,Appelman-Dijkstra NM,Papapoulos SE

    更新日期:2017-03-01 00:00:00

  • SIBLING family genes and bone mineral density: association and allele-specific expression in humans.

    abstract::Osteoporosis is a common complex disorder with reduced bone mineral density (BMD) and increased susceptibility to fracture. Peak BMD is one of the primary determinants of osteoporotic fracture risk, and is under substantial genetic control. Extracellular matrix, a major component of the bone, influences BMD by regulat...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.04.013

    authors: Alam I,Padgett LR,Ichikawa S,Alkhouli M,Koller DL,Lai D,Peacock M,Xuei X,Foroud T,Edenberg HJ,Econs MJ

    更新日期:2014-07-01 00:00:00

  • Polymorphisms in genes implicated in base excision repair (BER) pathway are associated with susceptibility to Paget's disease of bone.

    abstract::Paget's disease of bone (PDB) is a chronic bone metabolic disorder. Currently, PDB is the second most frequent bone disorder. PDB is a focal disorder affecting the skeleton segmentally but the cause of which is unknown. It has been hypothesised that somatic mutations could be responsible for the mosaicism described in...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.04.003

    authors: Usategui-Martín R,Gutiérrez-Cerrajero C,Jiménez-Vázquez S,Calero-Paniagua I,García-Aparicio J,Corral-Gudino L,Del Pino-Montes J,González-Sarmiento R

    更新日期:2018-07-01 00:00:00

  • Stronger back muscles reduce the incidence of vertebral fractures: a prospective 10 year follow-up of postmenopausal women.

    abstract::The long-term protective effect of stronger back muscles on the spine was determined in 50 healthy white postmenopausal women, aged 58-75 years, 8 years after they had completed a 2 year randomized, controlled trial. Twenty-seven subjects had performed progressive, resistive back-strengthening exercises for 2 years an...

    journal_title:Bone

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s8756-3282(02)00739-1

    authors: Sinaki M,Itoi E,Wahner HW,Wollan P,Gelzcer R,Mullan BP,Collins DA,Hodgson SF

    更新日期:2002-06-01 00:00:00

  • Effects of recreational team handball on bone health, postural balance and body composition in inactive postmenopausal women - A randomised controlled trial.

    abstract::This study reports the effects of a recreational team handball exercise programme (randomised controlled trial, RCT) on bone health, postural balance and body composition in inactive postmenopausal women without previous experience of the sport. Sixty-seven postmenopausal women (68.3 ± 6.2 years, stature 156.9 ± 5.8 c...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2021.115847

    authors: Pereira R,Krustrup P,Castagna C,Coelho E,Santos R,Helge EW,Jørgensen NR,Magalhães J,Póvoas S

    更新日期:2021-01-13 00:00:00

  • Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice.

    abstract::Trabecular bone score (TBS) is a recently-developed analytical tool that performs novel grey-level texture measurements on lumbar spine dual X-ray absorptiometry (DXA) images, and thereby captures information relating to trabecular microarchitecture. In order for TBS to usefully add to bone mineral density (BMD) and c...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2015.05.016

    authors: Harvey NC,Glüer CC,Binkley N,McCloskey EV,Brandi ML,Cooper C,Kendler D,Lamy O,Laslop A,Camargos BM,Reginster JY,Rizzoli R,Kanis JA

    更新日期:2015-09-01 00:00:00

  • Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias.

    abstract::Achondroplasia (ACH) and thanatophoric dysplasia (TD) are human skeletal disorders of increasing severity accounted for by mutations in the fibroblast growth factor receptor 3 (FGFR3). Attempts to elucidate the molecular signaling pathways leading to these phenotypes through mouse model engineering have provided relev...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2003.09.002

    authors: Legeai-Mallet L,Benoist-Lasselin C,Munnich A,Bonaventure J

    更新日期:2004-01-01 00:00:00